Recruiting Fabry Disease Studies in New York
About Fabry Disease Clinical Trials in New York
Fabry disease is a rare genetic disorder caused by deficiency of the enzyme alpha-galactosidase A, leading to accumulation of a fatty substance in cells. It can affect the heart, kidneys, and nervous system. Treatment includes enzyme replacement therapy and chaperone therapy.
There are currently 1 fabry disease clinical trials recruiting participants in New York, NEW%20YORK. These studies are seeking a combined 12 participants. Research is being sponsored by UniQure Biopharma B.V.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Fabry Disease Clinical Trials in New York — FAQ
Are there fabry disease clinical trials in New York?
Yes, there are 1 fabry disease clinical trials currently recruiting in New York, NEW%20YORK. Browse the studies on this page to find one that fits.
How do I join a clinical trial in New York?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New York research site will contact you about next steps.
Are clinical trials in New York free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New York studies also compensate for your time and travel.
What fabry disease treatments are being tested?
The 1 active trials in New York are testing new therapies including novel drugs, biologics, and treatment approaches for fabry disease.
Data updated March 2, 2026 from ClinicalTrials.gov